针对三阴性乳腺癌的癌症干细胞的转化药物
Felipe P de Oliveira1, Mateus L Nogueira1, Alexandre F C Galvão1
1Gonçalo Moniz Institute, Oswaldo Cruz Foundation (IGM-FIOCRUZ/BA), Salvador, Bahia 40296-710, Brazil.
Molecular therapy. Oncology
|July 21, 2025
概括
三阴性乳腺癌 (TNBC) 是具有攻击性和难以治疗的. 本综述探讨了通过抑制关键细胞信号通路来向癌症干细胞 (CSCs),以改善TNBC治疗结果.
科学领域:
- 在瘤学瘤学.
- 癌症生物学 癌症生物学
- 干细胞研究 干细胞研究
背景情况:
- 三阴性乳腺癌 (TNBC) 缺乏ER,PR和HER2表达,导致预后不佳和治疗选择有限.
- 癌症干细胞 (CSCs) 驱动TNBC中的瘤启动,转移,复发和耐药性.
- 针对CSC是一个有希望的策略,以克服TNBC的侵略性.
研究的目的:
- 审查针对细胞信号通路的化合物,这些化合物对TNBC干细胞生存和自我更新至关重要.
- 探索消除TNBC干细胞的潜在治疗策略.
主要方法:
- 对针对特定细胞信号通路的化合物的文献综述.
- 专注于包括,NF-κB,Wnt,Notch,Hippo,TGF-β,JAK/STAT和PI3K/AKT/mTOR在内的途径.
- 分析它们在TNBC干细胞生物学中的作用.
主要成果:
- 几种细胞信号通路 (刺,NF-κB,Wnt,Notch,Hippo,TGF-β,JAK/STAT,PI3K/AKT/mTOR) 对TNBC中枢细胞至关重要.
- 这些途径的抑制剂显示出TNBC干细胞根除的潜力.
- 针对这些途径可能会克服治疗耐药性并改善治疗结果.
结论:
- 准细胞信号通路为TNBC提供了一个有前途的治疗途径.
- 通过这些途径抑制CSC可能会导致三阴性乳腺癌的更有效的治疗方法.
- 对这些向疗法的进一步研究有必要进行临床转化.
相关概念视频
02:57Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
01:15Drugs that Stabilize Microtubules
2.1K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.1K
02:40Cancer Stem Cells and Tumor Maintenance
5.0K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.0K
01:10Drugs that Destabilize Microtubules
2.0K
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
2.0K
02:50Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K